Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries said Wednesday that its ordinary general meeting (OGM) has approved the estimated budget draft for fiscal year 2017/2018.

The OGM also adopted the investment budget for the next fiscal year, according to a bourse filing.

The company had earlier said that it targets to achieve profits worth EGP 24.5 million in the estimated budget set for FY17/18 in comparison to EGP 24.25 million for the current fiscal year.